Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mutagenesis ; 36(4): 295-301, 2021 08 27.
Artigo em Inglês | MEDLINE | ID: mdl-34086936

RESUMO

Mycotoxin fumonisin B1 (FB1) is a secondary metabolite that is produced by certain Fusarium species. Although numerous studies demonstrate toxic and carcinogenic effects of FB1, the underlying mechanisms have not been fully elucidated. In this study, we evaluated the epigenetic effects of FB1 for the first time using FLO assays, which detect epigenetic changes that affect the flocculation gene (FLO1) promoter activity in budding yeast. FLO assays showed increased reporter activities of the FLO1 promoter in the presence of 10 and 20 µM FB1. FB1 (20 µM) treatments also promoted flocculation. In subsequent in vitro methylation assays of a bacterial DNA methyltransferase (DNMT), FB1 treatments increased DNMT activities. Moreover, global DNA methylation was significantly increased in HEK293 cells treated with 100 µM FB1. Taken together, these results suggest that FB1 exposure leads to unique epigenetic alterations due to increased DNMT activities and demonstrate that FB1 may be an important risk factor for epigenetic dysfunction-associated human diseases including cancer.


Assuntos
Metilação de DNA , Fumonisinas/farmacologia , Lectinas de Ligação a Manose/genética , Regiões Promotoras Genéticas , Proteínas de Saccharomyces cerevisiae/genética , Epigênese Genética , Células HEK293 , Humanos , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética
2.
Mutagenesis ; 34(2): 173-180, 2019 05 29.
Artigo em Inglês | MEDLINE | ID: mdl-30852619

RESUMO

The mycotoxin ochratoxin A (OTA) is considered to be a human carcinogen. However, the mode of its carcinogenetic action has not been elucidated. Recently, it has become evident that epigenetic changes influence the risk of developing cancer. Since it has been revealed that the yeast flocculation displayed by the strains transformed with human DNA methyltransferases (DNMT) can be regulated by epigenetic mechanisms, we examined the effect of OTA on the transcription level of FLO1, which mediates the flocculation phenotype. OTA but not a non-carcinogenetic mycotoxin deoxynivalenol (DON) inhibited the intensity of GFP fluorescence under the transcriptional regulation of FLO1 promoter in a dose-dependent manner. At the same time, OTA had no effect on the reporter activity under the control of modified FLO1 promoter with reduced CpG motifs. In addition, it was confirmed that the flocculation and FLO1 mRNA of DNMT gene-transformed yeast (DNMT yeast) were decreased by OTA. In vitro methylation assay using a bacterial DNMT revealed an inhibitory effect of OTA on the DNMT activity, and OTA treatment reduced the frequency of abnormally shaped nuclei which were often observed in DNMT yeast. These results suggest that the carcinogenicity of OTA may involve inhibition of DNMT-mediated epigenetic regulation.


Assuntos
Carcinógenos/toxicidade , DNA (Citosina-5-)-Metiltransferase 1/antagonistas & inibidores , Ocratoxinas/toxicidade , DNA (Citosina-5-)-Metiltransferase 1/genética , DNA (Citosina-5-)-Metiltransferase 1/metabolismo , Metilação de DNA/efeitos dos fármacos , Epigênese Genética , Floculação/efeitos dos fármacos , Genes Reporter/efeitos dos fármacos , Lectinas de Ligação a Manose/genética , Lectinas de Ligação a Manose/metabolismo , Regiões Promotoras Genéticas , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Tricotecenos/farmacologia
3.
J Toxicol Sci ; 41(2): 273-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26961612

RESUMO

Macrophages induce the innate immunity by recognizing pathogens through Toll-like receptors (TLRs), which sense pathogen-associated molecular patterns. Myeloid differentiation factor 88 (MyD88), which is an essential adaptor molecule for most TLRs, mediates the induction of inflammatory cytokines through nuclear factor κB (NF-κB). Trichothecene mycotoxin deoxynivalenol (DON) shows immunotoxic effects by interrupting inflammatory mediators produced by activated macrophages. The present study investigates the effect of DON on NF-κB in activated macrophages through MyD88-dependent pathways. DON inhibited NF-κB-dependent reporter activity induced by MyD88-dependent TLR agonists. In addition, lipopolysaccharide-induced phosphorylation of interleukin-1 receptor-associated kinase 1 and inhibitor κBα were attenuated by DON. Furthermore, DON downregulated the expression level of MyD88. These results suggest that DON inhibits NF-κB activation in macrophages stimulated with TLR ligands via MyD88-dependent TLR signals. Therefore exposure to DON may lead to the inhibition of MyD88-dependent pathway of TLR signaling.


Assuntos
Micotoxinas/toxicidade , Fator 88 de Diferenciação Mieloide/fisiologia , NF-kappa B/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Receptores Toll-Like/imunologia , Tricotecenos/toxicidade , Animais , Células Cultivadas , Citocinas/metabolismo , Depressão Química , Regulação para Baixo/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Humanos , Imunidade Inata/genética , Imunidade Inata/imunologia , Mediadores da Inflamação/metabolismo , Lipopolissacarídeos , Macrófagos/imunologia , Macrófagos/metabolismo , Camundongos , Monócitos , Fator 88 de Diferenciação Mieloide/genética , Células RAW 264.7 , Transdução de Sinais/fisiologia , Receptores Toll-Like/agonistas
4.
Mycotoxin Res ; 29(4): 229-34, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23897301

RESUMO

The present study evaluated the immunotoxicity of citrinin (CIT), a mycotoxin produced by several Aspergillus, Penicillium, and Monascus species. Because nitric oxide (NO), a pro-inflammatory mediator, plays an important role in the protection from pathogens, we addressed the effect of CIT on NO production by a mouse macrophage-like cell line RAW264 activated with lipopolysaccharide (LPS). LPS-induced NO release from RAW264 cells was inhibited by CIT. Moreover, the transcription and expression of inducible NO synthase (iNOS) by LPS was suppressed by CIT. These results show that CIT suppressed the LPS-induced NO production and iNOS expression, which contribute to the host protection against invading pathogens. This suggests that CIT on LPS-induced NO release may exert adverse effects in macrophages, indicating immunotoxic effects of this toxin. .


Assuntos
Citrinina/imunologia , Fungos/imunologia , Regulação Enzimológica da Expressão Gênica/imunologia , Macrófagos/imunologia , Óxido Nítrico Sintase Tipo II/imunologia , Óxido Nítrico/biossíntese , Animais , Western Blotting , Linhagem Celular , Sobrevivência Celular/imunologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Macrófagos/enzimologia , Camundongos , Óxido Nítrico/análise , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores
5.
Mycotoxin Res ; 28(3): 163-8, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23606123

RESUMO

Leucocytes are susceptible to the toxic effects of deoxynivalenol (DON), which is a trichothecene mycotoxin produced by a number of fungi including Fusarium species. One mechanism of action is mediated by reactive oxygen species (ROS). The liver is an important target for toxicity caused by foreign compounds including mycotoxins. On the other hand, little is known about the influence of the redox state on hepatocytes treated with DON. The present study investigated the effect of DON on the cytosolic redox state and antioxidative system in the human hepatoma cell line HepG2. The cell viability of human monocyte cell line THP-1 or leukemia cell line KU812 treated with 2.5 and 5 µmol/l DON were significantly reduced. However, HepG2 cells showed no toxic effects under the same conditions and did not exhibit an increased oxidative state. Further experiments showed that thioredoxin-1 (Trx-1) protein levels but not glutathione increased in the cells treated with 10 µmol/l DON. In addition, the enhancement of Trx-1 content was repressed by antioxidants. These results suggest that DON-induced accumulation of Trx-1 in HepG2 cells plays one of the key roles in protection against cytotoxicity caused by DON and that the mechanism may be mediated by the antioxidant properties of Trx-1.


Assuntos
Antioxidantes/metabolismo , Hepatócitos/efeitos dos fármacos , Leucócitos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Tiorredoxinas/metabolismo , Tricotecenos/toxicidade , Antioxidantes/farmacologia , Linhagem Celular , Células Hep G2/efeitos dos fármacos , Humanos , Micotoxinas/farmacologia , Micotoxinas/toxicidade , Oxirredução , Espécies Reativas de Oxigênio/metabolismo , Espécies Reativas de Oxigênio/farmacologia , Tiorredoxinas/farmacologia , Tricotecenos/metabolismo , Tricotecenos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA